
| 2018 | |
|---|---|
| Criterium: | Position: |
| Overall Score: | > 1000 |
| Total Project Funding per Partner: | > 1000 |
| Total Number of Projects: | > 1000 |
| Networking Rank (Reputation): | > 1000 |
| 2015 | |
| Criterium: | Position: |
| Overall Score: | > 1000 |
| Networking Rank (Reputation): | > 1000 |
| 2012 | |
| Criterium: | Position: |
| Overall Score: | > 1000 |
| Networking Rank (Reputation): | > 1000 |
| Networking Rank (Reputation): | > 1000 |
Total number of projects: 3
As coordinator: 0
As participant: 3
Sole participant: 0
Coordinator / Participant Ratio: 0*
| Total project funding [€]: | Projects [No]: | |||||
|---|---|---|---|---|---|---|
| Year: | coordinator* | participant* | per partner | as coordinator | as participant | |
| 2018 | 0 | 4.075.132 | 0 | 1 | ||
| 2015 | 0 | 7.898.782 | 768.959 | 1 | ||
| 2012 | 0 | 5.983.871 | 747.984 | 1 | ||
Total number of partners: 30
Partner loyalty:
Frequent Partner: (> 2 projects): 0
Rare Partner: 30
Frequent / Rare Partner Ratio: 0
| Start date | Project | acronym | role | funding | partners |
|---|---|---|---|---|---|
| 2018-10-01 | Glyco-Nanoparticles for Applications in Advance Nanomedicine | NanoCarb | participant | 4.075.132 | 16 |
| 2015-02-01 | The Development of Medium- and Large-Scale Sustainable Manufacturing Process Platforms for Clinically Compliant Solid Core Nanopharmaceuticals | NANOFACTURING | participant | 7.898.782 | 9 |
| 2012-09-01 | Beta cell preservation via antigen-specific immunotherapy in Type 1 Diabetes: Enhanced Epidermal Antigen Delivery Systems. | EE-ASI | participant | 5.983.871 | 8 |